KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Return on Sales (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Return on Sales for 13 consecutive years, with 0.75% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 5.0% to 0.75% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.69% through Dec 2025, down 9.0% year-over-year, with the annual reading at 0.69% for FY2025, 9.0% down from the prior year.
  • Return on Sales hit 0.75% in Q4 2025 for ClearPoint Neuro, down from 0.66% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.54% in Q1 2024 to a low of 1.2% in Q2 2023.
  • Historically, Return on Sales has averaged 0.79% across 5 years, with a median of 0.74% in 2025.
  • Biggest five-year swings in Return on Sales: tumbled -47bps in 2021 and later soared 64bps in 2024.
  • Year by year, Return on Sales stood at 0.97% in 2021, then grew by 11bps to 0.86% in 2022, then grew by 20bps to 0.69% in 2023, then dropped by 0bps to 0.69% in 2024, then dropped by -8bps to 0.75% in 2025.
  • Business Quant data shows Return on Sales for CLPT at 0.75% in Q4 2025, 0.66% in Q3 2025, and 0.63% in Q2 2025.